ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
Author(s): Howard M, Frizzell DM, Bedwell DM
Source: NATURE MEDICINE    Volume: 2    Issue: 4    Pages: 467-469    Published: APR 1996  
Times Cited: 171     References: 20     
Abstract: Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR). A single recessive mutation, the deletion of phenylalanine 508 (Delta F508), causes severe CF and resides on 70% of mutant chromosomes. Severe CF is also caused by premature stop mutations, which are found on 5% of CF chromosomes. Here we report that two common, disease-associated stop mutations can be suppressed by treating cells with low doses of the aminoglycoside antibiotic G-418. Aminoglycoside treatment resulted in the expression of full-length CFTR and restored its cyclic AMP-activated chloride channel activity. Another aminoglycoside, gentamicin, also promoted the expression of full-length CFTR. These results suggest that treatment with aminoglycosides may provide a means of restoring CFTR function in CF patients with this class of mutation.
Document Type: Article
Language: English
Addresses:
1. UNIV ALABAMA, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA
2. UNIV ALABAMA, DEPT PHYSIOL, BIRMINGHAM, AL 35294 USA
3. UNIV ALABAMA, DEPT BIOPHYS, BIRMINGHAM, AL 35294 USA
Publisher: NATURE PUBLISHING CO, 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707
Subject Category: Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
IDS Number: UD314
ISSN: 1078-8956
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo